SP1 and epilepsy: Using mouse and cell epilepsy models, Zhang et al. (2022) found that NLRP3 inflammasome activation could enhance the expression of adenosine kinase and accelerate epilepsy via regulating CREB/REST/SP1 signaling pathway (Zhang et al., 2022).